Advertisement

Childhood Cancer in Minorities

  • Jan van Eys

Abstract

Childhood cancer is curable more often than not. This claim can be made with confidence. It is not an extrapolation from limited research experience when the claim is made that if all children were treated similarly, the cure rate would be greater than 50%. Rather, the curability of childhood cancer is now reflected in the vital statistics of the United States (Miller and McKay 1984). This excellent result is also seen in Western European countries, but it is not shared worldwide. The treatment of childhood cancers is arduous, prolonged, and expensive. Only a rich nation can afford pediatric cancer care as it is currently delivered in the United States.

Keywords

Acute Lymphocytic Leukemia Childhood Cancer White Child Black Child Pediatric Oncology Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bloom BS, Knorr RS, Evans AE: The epidemiology of disease expenses. The costs of caring for children with cancer. JAMA 1985;253:2393–2397.PubMedCrossRefGoogle Scholar
  2. Budowle B, Dearth J, Bowman P, et al: Genetic predisposition to acute lymphocytic leukemia in American blacks. A Pediatric Oncology Group study. Cancer 1985;55:2880–2882.PubMedCrossRefGoogle Scholar
  3. Crist W, Boyett J, Pullen J, et al: Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: A Pediatric Oncology Group review. Med Pediatr Oncol 1986;4:135–139.CrossRefGoogle Scholar
  4. Crist W, Boyett J, Roper M, et al: Pre-B cell leukemia responds poorly to treatment: A Pediatric Oncology Group study. Blood 1984;63:407–414.PubMedGoogle Scholar
  5. Haddy TB: Cancer in black children. Am J Pediatr Hematol Oncol 1982:4:285–292.PubMedGoogle Scholar
  6. Hammond D, Chard R, D’Angio GJ, et al: Pediatric malignancies. In Hoogstraten B (ed): Cancer Research: Impact of the Cooperative Groups. New York: Masson Publishing, 1980, pp 1–23.Google Scholar
  7. Huvos AG, Butler A, Bretsky SS: Osteogenic sarcoma in the American black. Cancer 1983;52:1959–1965.PubMedCrossRefGoogle Scholar
  8. Kramer S, Meadows AT, Jarrett P, et al: Incidence of childhood cancer: Experience of a decade in a population-based registry. JNCI 1983;70:49–55.PubMedGoogle Scholar
  9. MacDougall LG, Jankowitz P, Cohn R, et al: Acute childhood leukemia in Johannesburg. Ethnic differences in incidence, cell type, and survival. Am J Pediatr Hematol Oncol 1986;8:43–51.PubMedCrossRefGoogle Scholar
  10. McWhirter WR, Smith H, McWhirter KM: Social class as a prognostic variable in acute lymphoblastic leukaemia. Med J Aust 1983;2:319–321.PubMedGoogle Scholar
  11. Michielutte R, Diseker A: Children’s perceptions of cancer in comparison to other chronic illnesses. J Chronic Dis 1982;35:843–852.PubMedCrossRefGoogle Scholar
  12. Miller RW, McKay FW: Decline in US childhood cancer mortality, 1950 through 1980. JAMA 1984;251:1567–1570.PubMedCrossRefGoogle Scholar
  13. Polednak AP: Primary bone cancer incidence in black and white residents of New York State. Cancer 1985;55:2883–2888.PubMedCrossRefGoogle Scholar
  14. van Eys J, Berry D, Crist W, et al: Effect of trimethoprim-sulfamethoxazole (TS) prophylaxis on outcome of childhood lymphocytic leukemia. Cancer 1987;59:19–23.PubMedCrossRefGoogle Scholar
  15. Wegman ME: Annual summary of vital statistics—1985. Pediatrics 1986;78:983–994.PubMedGoogle Scholar
  16. Young JL Jr, Ries LG, Silverberg E, et al: Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 1986;58:598–602.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1989

Authors and Affiliations

  • Jan van Eys

There are no affiliations available

Personalised recommendations